Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AAAAI news: BM-144 as a new lead TxA2 antagonist molecule for asthma, thrombosis

March 7, 2000

Tyrosine kinase inhibitor D-58 is a potent antiallergic, antiinflammatory agent

March 7, 2000

Modulators of CCR5 receptor and their use presented by SmithKline Beecham

March 7, 2000

Rupatadine inhibits TNF-alpha release, may have potential in late-phase allergic reactions

March 6, 2000

Exploratory human studies with PNU-142731A reported at AAAAI meeting

March 6, 2000

Phase I/II trial examines multiple doses of IL-4R in asthmatic patients

March 6, 2000

AAAAI news: icatibant effective in reducing antigen-induced nasal hyperresponsiveness in SAR

March 6, 2000

NicOx presents nitrate salts of respiratory medications with improved tolerance

March 6, 2000

EpiGenesis and Taisho sign binding letter of intent for EPI-2010

March 3, 2000

FDA approves new Allegra formulations

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...